How Does GLP-1 Work? The Mechanism Behind Wegovy and Similar Medicines

GLP-1 is an incretin hormone — a chemical messenger released by cells in the small intestine in response to food. When levels of GLP-1 rise, several things happen at once: the pancreas is prompted to release insulin in a glucose-dependent way, the emptying of food from the stomach slows down, and signals are sent to the brain that register fullness and reduce appetite. Many people on GLP-1 medicines describe a quietening of "food noise" — the persistent mental preoccupation with food that can make eating less very difficult.

Prescription GLP-1 receptor agonists work by binding to the same receptors that natural GLP-1 targets, but with a much longer duration of action. Natural GLP-1 is broken down within minutes; these medicines are engineered to remain active for days, which is why a single weekly injection can produce sustained effects throughout the week.

It is worth noting that Mounjaro (tirzepatide) acts on two receptors rather than one — it targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. You can read more about this in the detailed breakdown of the GLP-1 agonist mechanism of action and the specific Mounjaro mechanism of action. For a broader look at how the GIP pathway adds to these effects, the page on the mechanism of action for GLP-1 agonists explores this further.

The slower gastric emptying effect — which contributes to that sense of lasting fullness — often becomes less pronounced over time as the body adjusts, though appetite effects commonly continue. According to NHS guidance, these medicines are intended to be used alongside dietary changes and increased physical activity as part of a supervised programme.

Understanding the mechanism is one thing; observing how it plays out in your own body is another. GLP-1 medicines affect appetite, energy, digestion, and mood differently from person to person, and those patterns often only become visible when you record them consistently over time.

GLP Trackr's daily check-in is built precisely for this. Each morning you can log your food-noise level, energy, mood, and sleep in around 30 seconds — creating a running record of how the medicine's effects shift as your dose is adjusted by your prescriber. Paired with the insights and analytics tools, the app can surface correlations you might not notice day to day: whether better sleep lines up with lower appetite, for example, or how your energy tracks across the week after each injection.

If you experience side effects commonly linked to the GLP-1 mechanism — such as nausea, reflux, or changes in digestion — the side-effect tracker lets you log these alongside your check-in data, giving you a clear picture to bring to your next prescriber appointment. The doctor report feature can help you summarise your journey in a format that is easy to share.

For a fuller guide to how these medicines work and what to expect week to week, visit how Mounjaro works — the main hub covering the science and the journey.

GLP Trackr is available free to download on the App Store and Google Play, with a 7-day free trial. Start logging how GLP-1 is working for you — your own data is the most relevant evidence you have.

GLP Trackr provides general information and tracking support only. Any questions about how your medication is affecting you, or any decisions about your dose or treatment, should always be discussed with your prescriber or doctor — they know your full medical history. If you experience symptoms that are severe or persistent, contact a healthcare professional promptly.